Objective : To evaluate the safety and acceptability of two transcervival application of 250 mg of quinacrine and 55.5 mg ibuproven pellets as non-surgical female sterilization. Design/data identification : A descriptive study was done by recruiting women seeking sterilization for family planning reason. Each women received a 250 mg dose of quinacrine hydrocloride in the form of seven cylindric…